CA2078347A1 - Use of copper(ii) containing compounds to accelerate wound healing - Google Patents

Use of copper(ii) containing compounds to accelerate wound healing

Info

Publication number
CA2078347A1
CA2078347A1 CA2078347A CA2078347A CA2078347A1 CA 2078347 A1 CA2078347 A1 CA 2078347A1 CA 2078347 A CA2078347 A CA 2078347A CA 2078347 A CA2078347 A CA 2078347A CA 2078347 A1 CA2078347 A1 CA 2078347A1
Authority
CA
Canada
Prior art keywords
copper
containing compounds
wound healing
accelerate
warm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2078347A
Other languages
French (fr)
Other versions
CA2078347C (en
Inventor
Loren R. Pickart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2078347A1 publication Critical patent/CA2078347A1/en
Application granted granted Critical
Publication of CA2078347C publication Critical patent/CA2078347C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Compositions of copper(II) containing compounds for use as active therapeutic substances, to accelerate healing of wounds in warm-blooded animals, and in the manufacture of medicaments for accelerating wound healing in warm-blooded ani-mals are disclosed. Methods of the present invention include systemic loading of copper(II) to accelerate the rate of wound heal-ing following injury or surgery. The copper(II) containing compounds include copper(II) complexes with amino acids and pep-tides, and copper(II) salts.
CA002078347A 1990-03-26 1991-03-26 Use of copper(ii) containing compounds to accelerate wound healing Expired - Lifetime CA2078347C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/499,606 US5164367A (en) 1990-03-26 1990-03-26 Method of using copper(ii) containing compounds to accelerate wound healing
US499,606 1990-03-26

Publications (2)

Publication Number Publication Date
CA2078347A1 true CA2078347A1 (en) 1991-09-27
CA2078347C CA2078347C (en) 1996-07-02

Family

ID=23985940

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002078347A Expired - Lifetime CA2078347C (en) 1990-03-26 1991-03-26 Use of copper(ii) containing compounds to accelerate wound healing

Country Status (8)

Country Link
US (1) US5164367A (en)
EP (1) EP0522004B1 (en)
JP (1) JPH05505808A (en)
AT (1) ATE187646T1 (en)
AU (1) AU7565091A (en)
CA (1) CA2078347C (en)
DE (1) DE69131847T2 (en)
WO (1) WO1991014437A2 (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX172248B (en) * 1989-12-20 1993-12-09 Univ Mexico PROCEDURE FOR THE OBTAINING OF NEW MIXED COPPER AMINO ACID COMPLEXES BASED ON FENYLATED PHENANTROLINS AS ANTI-CANCER AGENTS
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
WO1995026198A1 (en) * 1994-03-28 1995-10-05 Skin Biology, Inc. Metal complexes of aloe extracts for skin and hair
WO1995026194A1 (en) * 1994-03-28 1995-10-05 Skin Biology, Inc. Allantoin-metal complexes for skin and hair
AU2231495A (en) * 1994-03-28 1995-10-17 Skin Biology, Inc. Starch-metal complexes for skin and hair
JPH07316192A (en) * 1994-05-27 1995-12-05 Hoechst Japan Ltd L-lysyl-glycyl-l-histidine and therapeutic agent for wound
US5656588A (en) * 1994-07-19 1997-08-12 Wake Forest University Wound healing formula
ES2081771B1 (en) * 1994-08-05 1996-10-01 Arredondo Javier Olaechea COMPOSITION OF A LIQUID PRODUCT FOR TOPICAL USE FOR BURNS AND BLOWS.
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
US6096861A (en) * 1997-03-18 2000-08-01 The Regents Of The University Of California Peptide-peptoid metal complexes
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
AU770999C (en) 1999-10-01 2005-04-21 Ampio Pharmaceuticals, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20030166510A1 (en) * 2000-10-11 2003-09-04 Pickart Loren R. Methods and compositions for increasing skin remodeling
WO2003030926A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
US20050209131A1 (en) * 2001-11-16 2005-09-22 Singleton Laura C Composition containing peptides complexed with a copper ion
AU2003247816A1 (en) * 2002-07-02 2004-01-23 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20040142853A1 (en) * 2002-11-07 2004-07-22 Procyte Corporation Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil
US20040197319A1 (en) * 2003-03-24 2004-10-07 Paul Harch Wound healing composition derived from low platelet concentration plasma
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
US6927205B2 (en) * 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
CA2526971A1 (en) * 2003-06-04 2005-01-06 Ebersytes, Llc Novel dermatological composition
US6927206B2 (en) 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
US20060246047A1 (en) * 2003-06-24 2006-11-02 Masaya Imoto Peptide wirh apoptosis-inhibiting activity
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
WO2006023465A1 (en) * 2004-08-18 2006-03-02 Procyte Corporation Polyethylene glycol-peptide copper complexes and compositions and methods related thereto
TW200700107A (en) * 2005-03-16 2007-01-01 Procyte Corp Methods and compositions for preventing and treating aging or photodamaged skin
WO2007087738A1 (en) * 2006-02-03 2007-08-09 Pentapharm Ag Biologically active tripeptides and copper complexes and salts thereof
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7927614B2 (en) 2006-02-03 2011-04-19 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
ES2283212B1 (en) * 2006-03-31 2008-08-16 Lipotec S.A. USEFUL SYNTHETIC PEPTIDES IN THE TREATMENT OF SKIN AND ITS USE IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS.
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776474C (en) 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9586989B1 (en) 2011-04-12 2017-03-07 Skin Biology, Inc. Non-toxic skin cancer therapy with copper peptides
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11083750B2 (en) * 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
WO2017049529A1 (en) 2015-09-24 2017-03-30 Innolife Co., Ltd. A pharmaceutical composition comprising a copper chelating tetramine and the use thereof
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10898724B2 (en) 2019-06-11 2021-01-26 Soletluna Holdings, Inc. Wearable phototherapy apparatus with anti-viral and other effects
US10716953B1 (en) * 2019-06-11 2020-07-21 Soletluna Holdings, Inc. Wearable phototherapy apparatus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194732A (en) * 1960-10-03 1965-07-13 Neuhauser Irene Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3832338A (en) * 1972-03-23 1974-08-27 Diagnostic Data Inc Orgotein production using a buffer solution containing divalent metal salts
US3758682A (en) * 1972-03-23 1973-09-11 Diagnostics Data Inc Pharmaceutical compositions comprising orgotein and their use
US4022888A (en) * 1975-09-09 1977-05-10 Diagnostic Data, Inc. Esterified orgotein
DE2700043C2 (en) * 1977-01-03 1983-12-08 Thera Gesellschaft für Patentverwertung mbH, 8036 Herrsching Means to improve blood circulation and wound healing
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue
US4287184A (en) * 1977-11-23 1981-09-01 The Massachusetts General Hospital Process for healing wounds
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4461724A (en) * 1981-10-28 1984-07-24 Nippon Zoki Pharmaceutical Co., Ltd. Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treating ulcer and thrombus with them
HU193289B (en) * 1984-06-19 1987-09-28 Universal Vegyipari Szoevetkez Cosmetical composition for treating hair and nail containing blood plasma concentrate as active agent
US4937230A (en) * 1985-01-24 1990-06-26 Procyte Corporation Method of healing wounds in horses
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US4767753A (en) * 1985-02-08 1988-08-30 Procyte Corporation Methods and compositions for preventing ulcers
US4665054A (en) * 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu
ATE103608T1 (en) * 1987-04-20 1994-04-15 Procyte Corp CHEMICAL DERIVATIVES OF GHL-CU.
AU1799588A (en) * 1987-05-11 1988-12-06 Procyte Corporation Method of tumor inhibition in warm-blooded animals
CA1323839C (en) * 1987-05-11 1993-11-02 Loren Ralph Pickart Methods for stimulating hair growth

Also Published As

Publication number Publication date
EP0522004A1 (en) 1993-01-13
AU7565091A (en) 1991-10-21
EP0522004B1 (en) 1999-12-15
WO1991014437A2 (en) 1991-10-03
WO1991014437A3 (en) 1991-11-28
DE69131847T2 (en) 2000-04-27
JPH05505808A (en) 1993-08-26
DE69131847D1 (en) 2000-01-20
ATE187646T1 (en) 2000-01-15
CA2078347C (en) 1996-07-02
US5164367A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
CA2078347A1 (en) Use of copper(ii) containing compounds to accelerate wound healing
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
AU549481B2 (en) Hair growing agent
AU3275689A (en) Process for stabilizing human albumin solutions and the solution obtained
EE02971B1 (en) Use of droloxyfene or its salts in the manufacture of a medicament for the treatment of bone diseases
IL75536A (en) Crystalline calcium pseudomonate,its preparation and pharmaceutical and veterinary compositions comprising it
CA2139385A1 (en) Products containing g-csf and tnf binding protein
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
AU7999787A (en) Active compounds for use in the treatment of tumors
EP0914826A4 (en) Wound healing accelerators
CA2091134A1 (en) Therapeutic agent for threatened abortion
EP0821969A3 (en) Medicinal Composition comprising TCF-II
CA2290739A1 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
EP0470431A2 (en) Use of fosfomycin pharmaceutically acceptable salts as a topical cicatrizer
ES8200363A1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them.
CA2097878A1 (en) Therapeutic agent for neutropenia
CA2036592A1 (en) Therapeutic agent for diabetic gangrene
EP0384302A3 (en) Use of ubenimex in the manufacture of a medicament for treating myelodysplastic syndrome
AU3117093A (en) New peptide and pseudopeptide compounds which are therapeutically active in the blood coagulation cascade, process for preparing them and pharmaceutical compositions containing them
AU639827B2 (en) New peptide and pseudopeptide compounds that are therapeutically active in the blood coagulation cascade, process for the preparation thereof, and pharmaceutical compositions containing them
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202